Africa News Ledger
SEE OTHER BRANDS

The most trusted news from Africa

Africa News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.

Press releases published on June 6, 2025

Anbessa MICE Launches to Redefine  Ethiopia’s MICE and Incentive Travel Landscape

Anbessa MICE Launches to Redefine Ethiopia’s MICE and Incentive Travel Landscape

Pioneering Sustainable and Premium MICE Experiences in Ethiopia ADDIS ABABA, ETHIOPIA, June 6, 2025 /⁨EINPresswire.com⁩/ -- Anbessa MICE, Ethiopia's newest and most dynamic MICE operator and Destination Management Company (DMC), officially launches to …

Speaker Karoline Frank Gains International Recognition Following Breakthrough Performance

Speaker Karoline Frank Gains International Recognition Following Breakthrough Performance

Karoline Frank from Bargteheide made waves at the International Speaker Slam on May 15, 2025, in Niedernhausen, Germany. NIEDERNHAUSEN, HESSEN, GERMANY, June 6, 2025 /⁨EINPresswire.com⁩/ -- Karoline Frank from Bargteheide made waves at the International …

ZA Miner Expands AI Cloud Mining Infrastructure Following User Growth Surge in Q2

ZA Miner Expands AI Cloud Mining Infrastructure Following User Growth Surge in Q2

London, UK, June 06, 2025 (GLOBE NEWSWIRE) -- LONDON, June 4, 2025 – ZA Miner, a cloud-based digital asset mining provider, announced today the completion of a large-scale upgrade to its artificial intelligence infrastructure, aimed at improving mining …

HashFly Launches Automated Cloud Mining Plan to Help Beginners Earn Real BTC Without Hardware

HashFly Launches Automated Cloud Mining Plan to Help Beginners Earn Real BTC Without Hardware

New York, USA, June 06, 2025 (GLOBE NEWSWIRE) -- HashFly, a global cloud mining service provider established in 2013, has launched an automated cloud mining plan designed to make Bitcoin mining more accessible to beginners. The new plan removes traditional …

European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy

European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy

Now approved in the EU, Duvyzat offers an important treatment option for delaying Duchenne muscular dystrophy (DMD) disease progression Duvyzat is an orally administered treatment for DMD in patients 6 years and older who are able to walk The approval is …

Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the results of its Annual Meeting of …

Trusted Best QFSCOIN Free Cloud Mining Launches Cloud Mining Option for Crypto Investors to Earn Bitcoin and Dogecoin

Trusted Best QFSCOIN Free Cloud Mining Launches Cloud Mining Option for Crypto Investors to Earn Bitcoin and Dogecoin

Lewes, DE, June 06, 2025 (GLOBE NEWSWIRE) -- QFSCOIN, a regulated cloud mining company headquartered in the United States, has announced the launch of a new free mining initiative this week, offering a $30 cloud mining contract to all new users. The move …

Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials

Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials

PRINCETON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet …

Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN

Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN

Robust proteinuria reduction and stable kidney function were maintained across a broad population of patients No new safety signals were observed New data presented at late-breaking session at the European Renal Association Congress Marketing applications …

NetworkNewsAudio Announces Audio Press Release (APR) on Emerging Powerhouse in Gold Industry

NetworkNewsAudio Announces Audio Press Release (APR) on Emerging Powerhouse in Gold Industry

AUSTIN, Texas, June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled " Next Gold Powerhouse Emerges as Prices Break Records," featuring ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF). To hear the …

Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors

Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors

HAMPTON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that Denice M. Torres has been elected to the company’s Board of Directors. "We are excited to welcome Denice to the Celldex Board of Directors," said …

Entrée Resources Announces Pause in Oyu Tolgoi Lift 1 Panel 1 Underground Development Work

Entrée Resources Announces Pause in Oyu Tolgoi Lift 1 Panel 1 Underground Development Work

VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) -- Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) announces the Entrée/Oyu Tolgoi joint venture (the “Entrée/Oyu Tolgoi JV” or “JV”) has paused Oyu Tolgoi Lift 1 Panel 1 …

TERRA BALCANICA ANNONCE UNE EXTENSION DE PLACEMENT FONDÉ SUR LA DISPENSE POUR FINANCEMENT DE L’ÉMETTEUR COTÉ

TERRA BALCANICA ANNONCE UNE EXTENSION DE PLACEMENT FONDÉ SUR LA DISPENSE POUR FINANCEMENT DE L’ÉMETTEUR COTÉ

NE PAS DIFFUSER AUX ÉTATS-UNIS OU PAR L’INTERMÉDIAIRE DES SERVICES D’INFORMATION DES ÉTATS-UNIS Vancouver, Colombie-Britannique, 06 juin 2025 (GLOBE NEWSWIRE) --  Terra Balcanica Resources Corp. (« Terra » ou la « Société ») (CSE : TERA; FRA : UB1) annonce …

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine – – VERITAC-2 …

BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries

BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries

RESEARCH TRIANGLE PARK, N.C., June 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that, following a positive recommendation from the Zorginstituut Nederland, ORLADEYO® (berotralstat) has been approved for the …

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate (PPi) efflux via on-target engagement of the ABCC6 …

Polpharma Group soutient l’action urgente de l’UE visant à garantir l’accès aux médicaments et à renforcer la souveraineté pharmaceutique européenne

Polpharma Group soutient l’action urgente de l’UE visant à garantir l’accès aux médicaments et à renforcer la souveraineté pharmaceutique européenne

AMSTERDAM, 06 juin 2025 (GLOBE NEWSWIRE) -- Polpharma Group, fabricant européen de produits pharmaceutiques de premier plan, s’est joint aux autres membres de l’association Medicines for Europe pour signer une lettre ouverte adressée aux Premiers ministres …

Die Polpharma Group unterstützt dringende Maßnahmen der EU zur Sicherung des Zugangs zu Arzneimitteln und zur Stärkung der pharmazeutischen Souveränität Europas

Die Polpharma Group unterstützt dringende Maßnahmen der EU zur Sicherung des Zugangs zu Arzneimitteln und zur Stärkung der pharmazeutischen Souveränität Europas

AMSTERDAM, June 06, 2025 (GLOBE NEWSWIRE) -- Die Polpharma Group, ein führender europäischer Pharmahersteller, hat sich anderen Mitgliedern von Medicines for Europe angeschlossen und einen offenen Brief an die Premierminister und Gesundheitsminister aller …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service